PAG
ASMB icon

Private Advisor Group’s Assembly Biosciences ASMB Stock Holding History

Private Advisor Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-25
Closed -$7K – 1686
2020
Q2 		$7K Buy
+25
New +$5.83K ﹤0.01% 3061

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Private Advisor Group's ASMB Position: Q3 2020 in Review

Private Advisor Group sold out of Assembly Biosciences (ASMB) in Q3 2020, closing a stake of 25 shares — an estimated $7K sold.

Private Advisor Group first reported a position in ASMB in Q2 2020 and held it in 1 quarter. The position peaked at $7K in Q2 2020. 118 funds tracked by Wall St. Rank hold ASMB as of Q3 2020.

  • Private Advisor Group reported no remaining Assembly Biosciences position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 25 Assembly Biosciences shares in Q3 2020, an estimated $7K.
  • Private Advisor Group first reported a position in Assembly Biosciences in Q2 2020 and held it in 1 quarter.
  • Private Advisor Group's Assembly Biosciences position peaked at $7K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.